A clear and responsible governance

A structure that ensures the implementation of our strategy and the fulfillment of our commitments.

At Provepharm, governance is central to a clear and responsible strategy. It is structured around a separation of responsibilities between:

The Board of Directors

chaired by Michel Feraud, which approves the overall strategy proposed by the General Management

The Executive Committee

led by Hélène Thomas, which is responsible for managing Provepharm’s operations

Michel FERAUD – Founder & CEO

Michel FERAUD, the founder of Provepharm, transformed a chemistry R&D service provider into an international specialty pharmaceutical company within a few years. For over 25 years, he has driven rapid growth through consistent investments in R&D and the global reach of his patented innovations. Committed to societal impact, he established the Provepharm Endowment Fund in 2020.

Hélène THOMAS – Deputy CEO

Hélène THOMAS, Deputy Chief Executive Officer of Provepharm, is a seasoned leader in the pharmaceutical sector. She possesses robust expertise in launching new therapies and driving company growth. Her leadership and ability to unite teams are major assets in steering Provepharm’s operations and implementing the strategy.

The Board of Directors

Composed of 10 experienced individuals, it is structured around 3 committees: the audit and risk committee, the nomination and remuneration committee, and the product strategy committee

Michel FERAUD

Founder & Chairman, Member of the nomination and remuneration committee and the product strategy committee

Christophe BARALOTTO

Co-founder of Provepharm, Member of the audit and risk committee

François GARNIER

Archimed Representative

Jean-François DEHECQ

Member of the nomination and remuneration committee

Priscilla DOUSSE

Independent Director, Chair of the nomination and remuneration committee

Yves L’EPINE

Thetys Invest Representative, Member of the product strategy committee

Philippe LUSCAN

Independent Director, Member of the product strategy committee

Véronique VEDRINE

Independent Director, Chair of the audit and risk committee

Christian NEUMANN

Independent Director, Past Business Development lead

Robert SEBBAG

Independent Director, Board Observer, Member of the product strategy committee

The Executive Committee

Composed of diverse expertise and experience, it is responsible for ensuring Provepharm's sustainable and profitable growth and for deploying the strategy at all levels of the company